Blog

EC says separate GMP for cell and gene therapies is necessary – In-PharmaTechnologist.com


In-PharmaTechnologist.com

EC says separate GMP for cell and gene therapies is necessary
In-PharmaTechnologist.com
The PIC/S raised concerns about the plan in a letter published Last week , arguing separate more flexible good manufacturing practice (GMP) rules that take the variability involved in making cell and gene therapies into account would put patient safety

and more »

2017-03-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.